Genalyte Inc.

28 articles about Genalyte Inc.

• Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform

  1/11/2021

  Genalyte, a leading diagnostics and analytics company, announced the closure of $50 million in financing.

• 

  BioSpace Movers & Shakers, Oct. 16

  10/16/2020

  Biopharma and life sciences companies bolster their leadership teams with these Movers & Shakers.

• Genalyte Expands Testing Capabilities to Houston With COVID-19 Antibody Testing

  7/14/2020

  Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, today announced its SARS-CoV-2 Multi-Antigen Serology Panel, is now available in Houston.

• Genalyte Announces Availability of its High-Speed COVID-19 Antibody Test

  4/27/2020

  First Instrument-Based, Rapid Test Uses Multi-Antigen Approach to Achieve Best-in-Class Sensitivity and Specificity, U.S. FDA EUA Submitted

• Genalyte Expands Laboratory Services Offering with Acquisition of BaseHealth

  4/25/2020

  Acquisition Blends Rapid Diagnostic Services with Cutting-edge Healthcare Analytics to Better Deliver Real-Time Value to Care Givers and Patients

• 

  Is There a Diagnostic Company to Rise From the Ashes of Theranos?

  1/30/2019

  Companies are filling in the gaps and the entire area of so-called “liquid biopsies” is hot these days, with companies like Guardant Health, Karius, Freenome, Apostle and GRAIL Bio entering the market. With this backdrop, let’s look at some companies working in the same field as the now-defunct T...

• Genalyte Awarded ISO 13485 Medical Device Manufacturing Certification

  1/24/2018

  The awarding of ISO 13485 certification marks a major milestone for the San Diego based biotech start-up, providing a critical industry standard for the production of medical devices to support its cloud laboratory diagnostic testing model.

• 

  6 Blood Testing Startups Hoping to be The Next Theranos - The Good Version

  1/12/2018

  A look at 6 up and coming blood-testing startups.

• With $36 Million in New Funding, Can Genalyte Achieve What Theranos Touted?

  11/21/2016

• Genalyte Release: New Clinical Study Demonstrates Feasibility Of Performing Multiplex ANA Testing On Whole Blood Via Finger-Stick In Physician Office Near-Patient Setting

  11/14/2016

• Genalyte Appoints William A. Hagstrom To Board Of Directors

  6/16/2016

• San Diego's Genalyte Locks In $44 Million Financing

  8/18/2015

• Biotech Firm Genalyte Inc. Announces Hiring Of Former Defense Department Advisor

  2/2/2015

• Genalyte Inc. Completes First Phase Of National Cancer Institute Grant Program

  1/28/2015

• Ebola Rapid Testing Platform Genalyte Inc. To Attend JP Morgan Health Care Conference

  1/7/2015

• Genalyte Inc. Touts 10-Minute Ebola Test

  10/22/2014

• Genalyte Inc. Expands Into Cancer Profiling With $1 Million NCI Grant to Develop Cancer Biomarker Panel; Establishes Collaborations With Three Cancer Research Centers

  10/18/2013

• Biomarker Panel Could Provide Simpler Type-I Diabetes Detection, Genalyte Inc. Reveals

  9/11/2013

• Genalyte Inc. and Barbara Davis Diabetes Center Collaborate to Advance Multiplexed Antigen Panel for Early Diagnosis of Type 1 Diabetes

  8/15/2013

• Genalyte Inc. Streamlines Immunogenicity Testing With Launch of MT-ADA&#0153 Assay for Real-Time Detection of Anti-Drug Antibodies

  4/3/2013